Metuchen Pharms Drug Patent Portfolio

Metuchen Pharms owns 1 orange book drug protected by 2 US patents Given below is the list of Metuchen Pharms's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6656935 Aromatic nitrogen-containing 6-membered cyclic compounds 27 Apr, 2025
Active
US7501409 Preparations for oral administration 05 May, 2023 Expired


Given below is the list of recent legal activities going on the following drug patents of Metuchen Pharms.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 27 Aug, 2020 US7501409 (Litigated)
Patent Term Extension Certificate 18 Mar, 2016 US6656935 (Litigated)
Notice of Final Determination -Eligible 18 Nov, 2015 US6656935 (Litigated)
FDA Final Eligibility Letter 21 Jan, 2015 US6656935 (Litigated)
transaction for FDA Determination of Regulatory Review Period 10 Jun, 2014 US6656935 (Litigated)
transaction for FDA Determination of Regulatory Review Period 09 May, 2014 US6656935 (Litigated)
Second letter to regulating agency to determine regulatory review period 19 Mar, 2014 US6656935 (Litigated)
Letter from FDA or Dept of Agriculture re PTE application 13 Feb, 2013 US6656935 (Litigated)
Initial letter Re: PTE Application to regulating agency 28 Sep, 2012 US6656935 (Litigated)
Patent Term Extension Application under 35 USC 156 Filed 18 Jun, 2012 US6656935 (Litigated)
Patent Issue Date Used in PTA Calculation 10 Mar, 2009 US7501409 (Litigated)
Recordation of Patent Grant Mailed 10 Mar, 2009 US7501409 (Litigated)
Email Notification 19 Feb, 2009 US7501409 (Litigated)
Issue Notification Mailed 18 Feb, 2009 US7501409 (Litigated)
Application Is Considered Ready for Issue 02 Feb, 2009 US7501409 (Litigated)


Metuchen Pharms's Family Patents

Metuchen Pharms drugs have patent protection in a total of 28 countries. It's US patent count contributes only to 9.7% of its total global patent coverage. 19 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Metuchen Pharms Drug List

Given below is the complete list of Metuchen Pharms's drugs and the patents protecting them.


1. Stendra

Stendra is protected by 2 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6656935 Aromatic nitrogen-containing 6-membered cyclic compounds 27 Apr, 2025
(6 months from now)
Active
US7501409 Preparations for oral administration 05 May, 2023
(1 year, 5 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Stendra's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List